After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. | In a new deal potentially ...

George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration ...

Privately held Dyno Therapeutics Inc. has added another notch to its adeno-associated virus (AAV) vectors development ...

Roche Holding AG is willing to pay more than $1 billion to solve one of the biggest challenges of gene therapy: delivery.The ...

With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy ...

Roche has inked a new deal with Dyno Therapeutics to develop next-generation AAV capsids for gene therapies targeting ...

US artificial intelligence (AI) to gene therapy focussed biotech Dyno Therapeutics today announced its second research ...

Roche will use Dyno’s technology, through which Dyno applies AI and high-throughput in vivo data collection to engineering AAV capsids.

Existing gene therapies have primarily used a small number of naturally occurring AAV vectors limited by low delivery efficiency as well as problems with pre-existing immunity and manufacturability.

It's not new. It's not shiny. Every single panel is eaten out by rust. Yet, it stands for fun. For class. For power. It was a poster car, a dream car for generations. And it is just that for the ...

But a session of E-tuning and another on an actual dyno was hugely beneficial to my humble Civic. Now, I’d tell anyone interested in hot rodding their car at all to look into computer tuning ...

In the second video the "move" is also used on that impressive dyno called Airstar, the 8B boulder problem in Rocklands freed in 2009 by Kilian Fischhuber. For the record: on that occasion the ...